UK hikes drug prices after pharma exodus

Angelini Ventures and EIB launch joint start-up financing

EU Commission presents new bioeconomy strategy

Novo Nordisk’s semaglutide fails in Alzheimer’s

Gilead acquires Sprint Bioscience TREX1 programme

Melatonin: a promising new approach in Alzheimer’s treatment